Product Description: Cinpanemab (BIIB054) is a human-derived monoclonal antibody that binds to α-synuclein. Cinpanemab can be used for the research of Parkinson's disease[1][2].
Applications: Neuroscience-Neurodegeneration
Formula: N/A
References: [1]Lang AE, et, al. Trial of Cinpanemab in Early Parkinson's Disease. N Engl J Med. 2022 Aug 4;387(5):408-420. /[2]Teng JS, et, al. Immunotherapies for Parkinson's Disease: Progression of Clinical Development. CNS Neurol Disord Drug Targets. 2021;20(9):802-813.
CAS Number: 2094516-02-4
Molecular Weight: N/A
Compound Purity: 95.00
Research Area: Neurological Disease
Solubility: H2O
Target: α-synuclein